5.4.6 Shedding and Secondary Exposure

Introduction

The issue of shedding and secondary exposure was prominently discussed during the NCI hearings in Regina, raising significant concerns about the implications of vaccinated individuals potentially transmitting vaccine-derived materials to unvaccinated individuals. The concept of shedding involves the release and subsequent transmission of vaccine components, such as spike proteins, through bodily fluids. This phenomenon and its potential health impacts were corroborated by evidence provided in the Regina NCI hearings.

Testimonies on Shedding and Secondary Exposure

Dr. Sabine Hazan

• Research Findings: Dr. Hazan’s research indicated that vaccinated individuals could shed the original strain of the COVID-19 virus. Her studies used genetic sequencing to detect the presence of the virus in fecal matter and suggested that the vaccines themselves might be responsible for spreading the virus, as vaccinated patients were found to carry and potentially transmit the original, un-mutated strain.

Dr. Pierre Kory

• Shedding Mechanism: Dr. Kory elaborated on the FDA’s definition of shedding, which involves the release of vaccine-related genetic materials through excreta, secreta, or the skin. He highlighted that Pfizer’s documentation acknowledged the shedding potential of their vaccines. However, mandated shedding studies, which are crucial to understanding the extent and impact of this phenomenon, were not conducted.

Dr. Marian Laderoute

• Health Risks: Dr. Laderoute focused on the toxic effects of the spike protein, which is known to cause micro-clotting in the blood. She indicated that individuals vaccinated with mRNA vaccines could potentially shed the spike protein for up to three months, posing health risks to those around them. Her review of data from the UK Office of National Statistics suggested an increase in mortality rates for both vaccinated and unvaccinated individuals following mass vaccination, supporting the hypothesis of harmful shedding.

Yvonne Nickel

• Personal Experience: Yvonne Nickel provided a personal account of experiencing adverse effects attributed to shedding. As a lactation consultant working with vaccinated mothers, she observed increased incidences of “tongue-tie“ in newborns. She also reported symptoms such as brain fog, abdominal pain, and increased blood pressure, which she linked to close contact with vaccinated individuals.

Corroborating Evidence from the 2023 NCI Report

General Findings on Shedding

• Spike Protein Toxicity: The 2023 NCI Report emphasized the toxic nature of the spike protein, which can lead to micro-clotting and other health issues. It also highlighted the potential for the spike protein to be shed from vaccinated individuals, posing a risk of secondary exposure to unvaccinated individuals.

• Regulatory Oversight and Studies: The 2023 NCI Report noted the lack of comprehensive shedding studies, which are essential to fully understand the implications of secondary exposure. The absence of such studies was a significant oversight, given the novel nature of mRNA technology and its widespread use during the pandemic.

Impact on Public Health and Policy

• Increased Mortality Rates: Analysis of mortality rates in the UK following the vaccine rollout showed an increase in all-cause mortality among both vaccinated and unvaccinated individuals. The data supported the notion that shedding could have adverse effects on public health beyond the direct impact of the virus itself.

• Informed Consent and Public Awareness: The 2023 NCI Report stressed the importance of Informed Consent, which was compromised by the lack of transparency regarding the potential for shedding. The Report called for more rigorous disclosure of vaccine risks and benefits to ensure that the public could make informed decisions.

Recommendations

The testimonies and the 2023 NCI Report highlight the need for:

1. Immediately Discontinuing Use of mRNA vaccines.

2. Comprehensive Shedding Studies: Conduct detailed studies on the shedding of vaccine-derived materials to understand the full scope and impact of secondary exposure.

3. Transparent Communication: Ensure that information about the risks of shedding and secondary exposure is transparently communicated to the public to support Informed Consent.

4. Regulatory Oversight: Strengthen regulatory oversight to mandate shedding studies for new vaccines and ensure that the results are publicly accessible.

5. Public Health Guidelines: Develop public health guidelines to mitigate the risks associated with shedding, particularly for vulnerable populations.

Addressing these concerns is crucial for maintaining public trust and ensuring that vaccine policies are based on comprehensive scientific evidence, safeguarding both individual and public health.